|
30 Sep 2023 |
Novartis completes divestment of ‘front of eye’ ophthalmology assets
|
|
28 Sep 2023 |
Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's disease
|
|
27 Sep 2023 |
Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
|
|
26 Sep 2023 |
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
|
|
20 Sep 2023 |
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
|
|
20 Sep 2023 |
Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
|
|
19 Sep 2023 |
Pharmanovia acquires global central nervous system (CNS) portfolio from Sanofi
|
|
12 Sep 2023 |
Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer
|
|
12 Sep 2023 |
Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform
|
|
11 Sep 2023 |
Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium
|
|
09 Sep 2023 |
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
|
|
05 Sep 2023 |
XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
|
|
01 Sep 2023 |
Otsuka Pharmaceutical to Acquire Mindset Pharma
|
|
01 Sep 2023 |
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases.
|
|
31 Aug 2023 |
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
|
|
29 Aug 2023 |
Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers
|
|
29 Aug 2023 |
Deargen and Serengen Partner to Accelerate Drug Discovery
|
|
23 Aug 2023 |
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
|
|
22 Aug 2023 |
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
|
|
16 Aug 2023 |
Chiesi Global Rare Diseases Announces Co-Development Agreement with Aliada Therapeutics to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
|
|
16 Aug 2023 |
Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
|
|
15 Aug 2023 |
Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
|
|
12 Aug 2023 |
HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells
|
|
11 Aug 2023 |
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
|
|
11 Aug 2023 |
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
|
